Mellanox Slumps On Management Resigns (RGEN, RFIL, NDZ, ZLCS, MLNX)
Repligen Corporation (NASDAQ:RGEN) increased 12.38% to $6.03 on a traded volume of 162k shares. The 52-week range for the stock is $2.90 and $7.29. The Company has Price/Sales ratio of 3.76 and Price/Book ratio of 2.41. The 50-Day Moving Average and 200-Day Moving Average prices is $4.80 and $4.80 respectively.
RF Industries Ltd (NASDAQ:RFIL) among the gainers and the stock augmented 20.0% to $4.80. The Company reported third quarter consolidated net income was $735 thousand or 10 cents per share compared to $64 thousand or 0.01 per share in the prior year period. Net sales were $7.47 million versus $4.94 million in the prior year period. Sales from Cables Unlimited were $2.72 million from $909 thousand last year. The Company’s Bioconnect sales increased 12% to $570 thousand.
Nordion Inc (USA) (NYSE:NDZ) declined 35.49% to $6.90 on a traded volume of 1.74 million shares. The Company has received the decision in the confidential arbitration with Atomic Energy of Canada Limited. Nordion was unsuccessful in its claim for specific performance or monetary damages relating to AECL’s cancelled construction of the MAPLE facilities. Thus, Nordion was not entitled to a remedy under the ILTSA for the unilateral termination by AECL of the construction of the MAPLE facilities.
Zalicus Inc (NASDAQ:ZLCS) declined 33.09% to $0.94 on a traded volume of 6.45 million shares. The Company announced top line results from its randomized, double-blind, placebo-controlled, Phase 2b clinical trial of Synavive in rheumatoid arthritis. The Phase 2b trial demonstrated that patients treated with Synavive achieved a statistically significant improvement in signs and symptoms of moderate to severe RA compared to placebo. The trial enrolled 259 subjects and was conducted in approximately 50 centers throughout the United States, Europe and Latin America.
Mellanox Technologies Ltd (NASDAQ:MLNX) slipped 9.86% to $99.95 on a traded volume of 2.81 million shares. The stock is down after the announcement of retirement Michael Grayer, the Company’s chief financial officer from his current position effective November 5, 2012. Jacob Shulman has been appointed the Company’s new chief financial officer.